The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: Results of a retrospective multi-institutional case series.
 
Anna Maria Frezza
Research Funding - GlaxoSmithKline/Novartis (Inst); Lilly (Inst)
 
Naofumi Asano
No Relationships to Disclose
 
Robin Jones
No Relationships to Disclose
 
Ravin Ratan
No Relationships to Disclose
 
Pawel Teterycz
Travel, Accommodations, Expenses - Bayer; PharmaMar
 
Hans Gelderblom
No Relationships to Disclose
 
Kjetil Boye
No Relationships to Disclose
 
Mehdi Brahmi
No Relationships to Disclose
 
Emanuela Palmerini
No Relationships to Disclose
 
Nadia Hindi
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Antonella Brunello
Consulting or Advisory Role - Lilly; PharmaMar
 
Ingrid Desar
No Relationships to Disclose
 
Giovanni Grignani
Honoraria - GlaxoSmithKline; Novartis
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst)
 
Alexander A. Fedenko
Honoraria - Amgen; GlaxoSmithKline; Johnson & Johnson
 
Bruno Vincenzi
Consulting or Advisory Role - Bayer; Eisai; Lilly; Novartis; Pfizer; PharmaMar
Research Funding - Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; PharmaMar
 
Zsuzsanna Papai
No Relationships to Disclose
 
Akira Kawai
No Relationships to Disclose
 
Salvatore Lo Vullo
No Relationships to Disclose
 
Paolo Giovanni Casali
Honoraria - Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - ARIAD/Merck; Bayer; Blueprint Medicines; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar
Research Funding - Amgen/Dompé (Inst); Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MolMed (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Karyopharm Therapeutics; Lilly; PharmaMar; Plexxikon
Research Funding - Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar